Synavive (prednisolone/dipyridamole) / Sun Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Synavive (prednisolone/dipyridamole) / Sun Pharma
NCT00747214 / 2004-001930-18: A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA

Completed
2
59
Europe
CRx-102, Prednisolone plus dipyridamole, Placebo, sugar pill, DMARD Therapy, Disease modifying anti-rheumatic drug therapy
Zalicus
Rheumatoid Arthritis
09/06
11/06
MARS-1, NCT00551707 / 2007-003069-42: Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis

Completed
2
51
US, Canada, Europe, RoW
CRx-102 (2.7/180), prednisolone 2.7 mg plus dipyridamole 180 mg, prednisolone, dipyridamole, dipyridamole 360 mg, placebo, CRx-102 (2.7/360), Prednisolone 2.7 mg plus Dipyridamole 360 mg
Zalicus
Rheumatoid Arthritis
11/08
01/09
COMET-1, NCT00521989: CRx-102 Osteoarthritis Multicenter Evaluation Trial

Terminated
2
279
US, Canada
CRx-102 (2.7/90), 2.7 mg prednisolone plus 90 mg dipyridamole, Prednisolone, 2.7 mg prednisolone, Placebo, CRx-102 (2.7/180), Prednisolong 2.7 mg plus dipyridamole 180 mg, CRx-102 (2.7/360), 2.7 mg prednisolone plus 360 mg dipyridamole
Zalicus
Knee Osteoarthritis
07/09
07/09
NCT01369745 / 2011-000436-28: A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis

Completed
2
294
US
Prednisolone, dipyridamole, Prednisone, Z102, prednisolone, placebo
Zalicus
Rheumatoid Arthritis
08/12
09/12
NCT01612377 / 2011-002392-41: Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis

Terminated
2
18
RoW
Prednisolone-Dipyridamole, Z102, Prednisone, prednisone
Zalicus
Rheumatoid Arthritis
07/13
09/13

Download Options